1,25-dihydroxyvitamin D as Predictor of Renal Worsening Function in Chronic Kidney Disease. Results From the PASCaL-1,25D Study
BackgroundHeterogeneous progression of chronic kidney disease (CKD) toward dialysis advocates improving in renal care management. Diagnosis and staging of CKD relies on estimated glomerular filtration rate (eGFR) and albuminuria. Tubular biomarkers emerged as new predictors of worsening renal functi...
Main Authors: | Andrea Galassi, Eliana Maria Fasulo, Paola Ciceri, Roberta Casazza, Fabrizio Bonelli, Claudia Zierold, Mariella Calleri, Frank A. Blocki, Maria Assunta Palmieri, Claudio Mastronardo, Mario G. Cozzolino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.840801/full |
Similar Items
-
Familial vitamin D resistant rickets: End-organ resistance to 1,25-dihydroxyvitamin D
by: Sangita Choudhury, et al.
Published: (2013-01-01) -
Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels in Breast Cancer Risk in Mali: A Case–Control Study
by: Aboubacar D. T. Bissan, et al.
Published: (2023-12-01) -
26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines
by: Samuel Seoane, et al.
Published: (2013-12-01) -
Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma
by: Dong Won Kim, MD, et al.
Published: (2021-05-01) -
Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy
by: Xiaoyun Zeng, et al.
Published: (2017-06-01)